These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 17538955)
1. The functional contrariety of JNK. Bode AM; Dong Z Mol Carcinog; 2007 Aug; 46(8):591-8. PubMed ID: 17538955 [TBL] [Abstract][Full Text] [Related]
2. From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance. Karin M; Gallagher E IUBMB Life; 2005; 57(4-5):283-95. PubMed ID: 16036612 [TBL] [Abstract][Full Text] [Related]
3. JNK signalling in cancer: in need of new, smarter therapeutic targets. Bubici C; Papa S Br J Pharmacol; 2014 Jan; 171(1):24-37. PubMed ID: 24117156 [TBL] [Abstract][Full Text] [Related]
4. JNK signaling as a target for anticancer therapy. Abdelrahman KS; Hassan HA; Abdel-Aziz SA; Marzouk AA; Narumi A; Konno H; Abdel-Aziz M Pharmacol Rep; 2021 Apr; 73(2):405-434. PubMed ID: 33710509 [TBL] [Abstract][Full Text] [Related]
5. c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Waetzig V; Czeloth K; Hidding U; Mielke K; Kanzow M; Brecht S; Goetz M; Lucius R; Herdegen T; Hanisch UK Glia; 2005 May; 50(3):235-46. PubMed ID: 15739188 [TBL] [Abstract][Full Text] [Related]
6. JNK, cytoskeletal regulator and stress response kinase? A Drosophila perspective. Goberdhan DC; Wilson C Bioessays; 1998 Dec; 20(12):1009-19. PubMed ID: 10048301 [TBL] [Abstract][Full Text] [Related]
7. MKK7γ1 reverses nerve growth factor signals: proliferation and cell death instead of neuritogenesis and protection. Haeusgen W; Herdegen T; Waetzig V Cell Signal; 2011 Aug; 23(8):1281-90. PubMed ID: 21406225 [TBL] [Abstract][Full Text] [Related]
8. Insulin-mediated cell proliferation and survival involve inhibition of c-Jun N-terminal kinases through a phosphatidylinositol 3-kinase- and mitogen-activated protein kinase phosphatase-1-dependent pathway. Desbois-Mouthon C; Cadoret A; Blivet-Van Eggelpoël MJ; Bertrand F; Caron M; Atfi A; Cherqui G; Capeau J Endocrinology; 2000 Mar; 141(3):922-31. PubMed ID: 10698166 [TBL] [Abstract][Full Text] [Related]
9. The isoform-specific functions of the c-Jun N-terminal Kinases (JNKs): differences revealed by gene targeting. Bogoyevitch MA Bioessays; 2006 Sep; 28(9):923-34. PubMed ID: 16937364 [TBL] [Abstract][Full Text] [Related]
10. The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer. Hammouda MB; Ford AE; Liu Y; Zhang JY Cells; 2020 Apr; 9(4):. PubMed ID: 32252279 [TBL] [Abstract][Full Text] [Related]
11. Prolactin stimulates activation of c-jun N-terminal kinase (JNK). Schwertfeger KL; Hunter S; Heasley LE; Levresse V; Leon RP; DeGregori J; Anderson SM Mol Endocrinol; 2000 Oct; 14(10):1592-602. PubMed ID: 11043575 [TBL] [Abstract][Full Text] [Related]
12. Role of the JNK pathway in human diseases. Sabapathy K Prog Mol Biol Transl Sci; 2012; 106():145-69. PubMed ID: 22340717 [TBL] [Abstract][Full Text] [Related]
13. TBP is differentially regulated by c-Jun N-terminal kinase 1 (JNK1) and JNK2 through Elk-1, controlling c-Jun expression and cell proliferation. Zhong S; Fromm J; Johnson DL Mol Cell Biol; 2007 Jan; 27(1):54-64. PubMed ID: 17074809 [TBL] [Abstract][Full Text] [Related]